Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VINC
VINC | US
0.01
USD0
0%
VINC | US
Loading StockChartView...
About VINC
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
0.01
Open
0.01
High
0.01
Low
0.01
Vincerx Pharma Inc. a clinical-stage biopharmaceutical company researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236 a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma Inc. was founded in 2019 is based in Palo Alto California.
View LessVINC | US
Risk
13.0
Sharpe
-0.54
Luna's Score
46/100
Recommendation
Hold
Luna says (VINC | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
18.0%1 month
13.0%3 months
14.3%6 months
206.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.75
Debt to equity
0.13
Debt to assets
0.09
Ent. to EBITDA
-3.13
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-29.93M
MarketCap
389.10K
MarketCap(USD)
389.10K
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-142.45
Short ratio
1.96
Short perc.
1.07
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.00
Range1M
0.01
Range3M
0.01
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.52
Price X volume
84.47
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.13 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.75 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 14.29 | 72.80 | Lower Risk |
| Debt to Equity | 0.13 | -1.23 | Expensive |
| Debt to Assets | 0.09 | 0.25 | Cheaper |
| Market Cap | 389.10K | 3.66B | Emerging |
